P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

July 2008

Features

Drug Forecast

Posaconazole (Noxafil), an Extended-Spectrum Oral Triazole Antifungal Agent

Drs. Chang and Chagan review posaconazole (Noxafil) for fungal infections.
Mei Chang, BA, PharmD, and Larisa Chagan, PharmD, BCPS

Profile

FDA’s Janet Woodcock Riding High

An in-depth interview with the director of the FDA’s Center for Drug Evaluation and Research reveals a conscientious leader who is receiving high marks for her candor about the agency’s challenges.
Stephen Barlas

Meeting Highlights

American Society of Clinical Oncology

Presentations cover therapies for breast cancer, renal cell carcinoma, chronic myelogenous leukemia, non–small-cell lung cancer, bone resorption, and melanoma.
Walter Alexander

Continuing Education Credit

The Pharmacological Management of Migraine, Part 1

Migraine is the most common headache complaint in clinical practice. Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.
George DeMaagd, PharmD, BCPS

The Law of Unintended Consequences: When Pain Management Leads to Medication Errors

In 2001, The Joint Commission released new pain guidelines and attempted to address the problem of undertreated pain; however, the resulting focus on the pain score number has inadvertently led to some serious adverse drug events. In addition, the recent dramatic increase in opioid use has resulted in greater abuse of these prescribed drugs, often by teenagers.
Steven Hanks, MD, MMM, FACP

Departments

Editorial

Myth Busters

David Nash, MD, MBA, debunks four myths about health care spending. For instance, it is widely known that the U.S. spends more on health care than other nations, but this is not because of drug costs or ­doctor fees.
David B. Nash, MD, MBA

Medication Errors

Lowdown on Lomustine

Matthew Grissinger, RPh, FASCP, describes common mishaps that can occur with lomustine (CCNU), a drug used to treat Hodgkin’s disease and brain cancer.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Dollars Start to Flow to Doctors for E-prescribing Efforts

Stephen Barlas wonders whether offering money to doctors who switch to electronic prescriptions will be enough of an incentive.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From becaplermin to zoledronic acid, P&T presents the latest information about FDA approvals, new indications, recalls, and industry updates.